Description
NexumLabs | Product information 01 — Description What is it? 01 / 03 BPC-157 10 mg BPC-157 is presented in this data sheet as a compound intended exclusively for in vitro laboratory research. Investigation of pathways related to tissue repair and regeneration in vitro. Important information: Compound intended exclusively for laboratory research. 02 — Certificate of Analysis Analytical data 02 / 03 Certificate of Analysis (COA) BATCH · NEXUMBPC004 Compound BPC-157 · 10 mg Assay (HPLC) +99% Purity Identity (MS) Confirmed 03 — Research What has been studied 03 / 03 What it is BPC-157 (body protection compound 157) is a pentadecapeptide, a partial sequence of a compound isolated from human gastric juice [2]. Sikiric et al. give its sequence as GEPPPGKPADDAGLV, with a molecular weight of 1419, and describe it as stable in human gastric juice [1]. It is not approved as a medicine. Gastrointestinal tract (review, 2011). Sikiric et al. reviewed studies, mostly in rats, on lesions of the oesophagus, stomach, intestine, liver and pancreas, on fistulas and on intestinal anastomoses, and described effects on angiogenesis, the endothelium and the nitric oxide system [1]. Tendon, in vitro (2011). Chang et al. found that BPC-157 accelerated the outgrowth of rat Achilles tendon explants and increased the survival of tendon fibroblasts under oxidative stress, and their migration, with activation of the FAK–paxillin pathway, while cell proliferation was not directly affected [2]. Angiogenic growth factors (review, 2018). Seiwerth et al. compared BPC-157 with EGF, FGF and VEGF across models of gastrointestinal healing and of tendon, ligament, muscle and bone healing [3]. Systematic review (2025). Vasireddi et al. included 36 studies: 35 preclinical and one clinical. The data they reviewed describe a half-life under 30 minutes, hepatic metabolism and renal clearance; the authors found no clinical safety data and noted that adverse effects are possible through unregulated manufacturing or contamination [4]. References Sikiric P, et al. Stable gastric pentadecapeptide BPC 157: novel therapy in gastrointestinal tract. Curr Pharm Des. 2011. doi:10.2174/138161211796196954. PubMed 21548867 Chang CH, et al. The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration. J Appl Physiol (1985). 2011. doi:10.1152/japplphysiol.00945.2010. PubMed 21030672 Seiwerth S, et al. BPC 157 and Standard Angiogenic Growth Factors. Gastrointestinal Tract Healing, Lessons from Tendon, Ligament, Muscle and Bone Healing. Curr Pharm Des. 2018. doi:10.2174/1381612824666180712110447. PubMed 29998800 Vasireddi N, et al. Emerging Use of BPC-157 in Orthopaedic Sports Medicine: A Systematic Review. HSS J. 2025. doi:10.1177/15563316251355551. PubMed 40756949 Important: For laboratory research use only. Not for human or veterinary use.
